Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report by Chen, Yuanbin, MD, PhD, Paz-Ares, Luis, MD, PhD, Reinmuth, Niels, MD, PhD, Garassino, Marina Chiara, MD, Statsenko, Galina, MD, Hochmair, Maximilian J., MD, Özgüroğlu, Mustafa, MD, PhD, Verderame, Francesco, MD, Havel, Libor, MD, Losonczy, György, MD, PhD, Conev, Nikolay V., MD, PhD, Hotta, Katsuyuki, MD, PhD, MPH, Ji, Jun Ho, MD, PhD, Spencer, Stuart, MSc, Dalvi, Tapashi, PhD, MPH, Jiang, Haiyi, MD, Goldman, Jonathan W., MD

Get full text

Expression of mesothelin in thymic carcinoma and its potential therapeutic significance by Thomas, Anish, MD, Chen, Yuanbin, MD PhD, Berman, Arlene, MS, Schrump, David S., MD, Giaccone, Giuseppe, MD PhD, Pastan, Ira, MD, Venzon, David J., PhD, Liewehr, David J., MS, Steinberg, Seth M., PhD, Miettinen, Markku, MD, Hassan, Raffit, MD, Rajan, Arun, MD

Get full text